World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
56286
World Ranking
6675
National Ranking
221

Overview

Nicoletta Colombo is affiliated with the University of Milano-Bicocca in Italy, focusing primarily on medical research. Their work spans multiple fields within medicine, with a concentrated interest in hematology, reproductive medicine, molecular biology, public health, environmental and occupational health, and oncology.

The scientist's research topics include:

  • Acute Myeloid Leukemia Research
  • Ovarian cancer diagnosis and treatment
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Multiple Myeloma Research and Treatments
  • Histone Deacetylase Inhibitors Research
  • Immune Cell Function and Interaction

Nicoletta Colombo has contributed to several recent publications, among them:

  • "Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden" (2020, Cancers)
  • "Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation" (2021, European Journal Of Haematology)
  • "Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer" (2025, International Journal of Gynecological Cancer)
  • "ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma." (2021, Journal of Clinical Oncology)
  • "Textbook oncologic outcome is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer" (2024, Gynecologic Oncology)

Their frequent co-authors include:

  • Paola Minetto
  • Fabio Guolo
  • Michele Cea
  • Roberto M. Lemoli
  • Elisabetta Tedone

The main venues in which Nicoletta Colombo publishes research are:

  • Blood
  • International Journal of Gynecological Cancer
  • HemaSphere
  • Gynecologic Oncology
  • Cancers

This profile reflects a detailed focus on both hematologic malignancies and gynecological cancers, demonstrating a multidisciplinary approach to medical research and clinical outcomes evaluation.

Best Publications

  • ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.

    Nicoletta Colombo;Carien Creutzberg;Frederic Amant;Tjalling Bosse

  • Maintenance Olaparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

    Kathleen Moore;Nicoletta Colombo;Giovanni Scambia;Byoung Gie Kim

  • Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

    Eric Pujade-Lauraine;Jonathan A Ledermann;Frédéric Selle;Val Gebski

  • Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

    MK Parmar;JA Ledermann;N Colombo;Bois A Du

  • Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.

    Isabelle Ray-Coquard;Patricia Pautier;Sandro Pignata;David Pérol

  • Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

    Robert L Coleman;Amit M Oza;Domenica Lorusso;Carol Aghajanian

  • ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

    Nicole Concin;Xavier Matias-Guiu;Ignace Vergote;David Cibula

  • Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    J.A. Ledermann;F.A. Raja;C. Fotopoulou;A. Gonzalez-Martin

  • ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

    N. Colombo;C. Sessa;A. du Bois;J. Ledermann

  • THE EFFECT OF DEBULKING SURGERY AFTER INDUCTION CHEMOTHERAPY ON THE PROGNOSIS IN ADVANCED EPITHELIAL OVARIAN CANCER. GYNECOLOGICAL CANCER COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER

    Maria E.L. van der Burg;Mat van Lent;Marc Buyse;Anna Kobierska

  • Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

    Michael A. Bookman;Mark F. Brady;William P. McGuire;Peter G. Harper

  • Ovarian Cancer: Screening, Treatment, and Follow-up

    Vicki Seltzer;Bruce H. Drukker;Brenda W. Gillespie;Lynn M. Gossfeld

  • European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

    E A Eisenhauer;W W ten Bokkel Huinink;K D Swenerton;L Gianni

  • Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    N. Colombo;N. Colombo;S. Carinelli;A. Colombo;C. Marini

  • Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial

    M. K B Parmar;M. Adams;M. Balestrino;K. Bertelsen

  • Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

    Nicoletta Colombo;Coraline Dubot;Domenica Lorusso;M Valeria Caceres

  • Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    N. Colombo;E. Preti;F. Landoni;S. Carinelli

  • Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

    Amit M Oza;David Cibula;Ana Oaknin Benzaquen;Christopher Poole

  • Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

    U.A. Matulonis;R. Shapira-Frommer;A.D. Santin;A.S. Lisyanskaya

  • European-Canadian randomized trial of Paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

    Elizabeth A. Eisenhauer;Wim W. ten Bokkel Huinink;Kenneth D. Swenerton;Luca Gianni

Frequent Co-Authors

Giovanni Scambia
Giovanni Scambia Catholic University of the Sacred Heart
Amit M. Oza
Amit M. Oza Princess Margaret Cancer Centre
Ana Oaknin
Ana Oaknin Vall d'Hebron Hospital Universitari
Sandro Pignata
Sandro Pignata National Cancer Institute
Jonathan A. Ledermann
Jonathan A. Ledermann University College London
Carol Aghajanian
Carol Aghajanian Memorial Sloan Kettering Cancer Center
Michael Friedlander
Michael Friedlander University of New South Wales
Valter Torri
Valter Torri Mario Negri Institute for Pharmacological Research
Domenica Lorusso
Domenica Lorusso Catholic University of the Sacred Heart

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens the door to a variety of educational and professional paths beyond a traditional medical degree. For those interested in healthcare leadership, pursuing one of the affordable online mha programs can prepare you for management roles in hospitals, clinics, and other healthcare facilities.

Advanced practice nurses looking to expand their expertise may be interested in exploring the cheapest dnp online programs. These programs offer flexibility without compromising on curriculum quality, helping nurses achieve the highest levels of clinical practice.

Those focused on the pharmaceutical side of healthcare may look into online pharmacy programs, which can lead to rewarding careers in both patient care and research.

If you are interested in the intersection of technology and healthcare, an online bachelor's in health information management can equip you with the skills needed to manage critical medical data and support healthcare operations efficiently.

Best Scientists Citing Nicoletta Colombo

Trending Scientists